Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate Other stock markets 06:55:54 2026-07-29 am EDT			5-day change	1st Jan Change
59.65 ^EUR	0.00%		+6.14%	-6.06%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.48B		BBB
ELI LILLY AND COMPANY	1,089B		A
JOHNSON & JOHNSON	643B		BBB
ABBVIE INC.	465B		AA	-
ROCHE HOLDING AG	359B		AA
NOVARTIS AG	303B		AAA
ASTRAZENECA PLC	267B		A
NOVO NORDISK A/S	226B		A
AMGEN INC.	212B		A
GILEAD SCIENCES, INC.	167B		AA
PFIZER INC.	144B		A
BRISTOL-MYERS SQUIBB COMPANY	130B		A
VERTEX PHARMACEUTICALS INCORPORATED	124B		AA
SANOFI	109B		AA
GSK PLC	108B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.35B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.03B		AA
BAYER AG	52.65B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	51.98B		AA
Average	232.19B		AA
Weighted average by Cap.			AA